Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $162 and $184, respectively); and amortized cost: $309,406 and $300,555, respectively	$ 293,779	$ 281,412
Equity securities	746	757
Contractholder-directed equity securities and fair value option securities, at estimated fair value	9,289	10,331
Mortgage loans (net of allowance for credit loss of $847 and $721, respectively)	90,415	92,506
Policy loans	8,822	8,788
Real estate and real estate joint ventures (includes $380 and $317, respectively, under the fair value option; $59 and $0, respectively, of real estate held-for-sale; $230 and $0, respectively, relating to variable interest entities)	13,731	13,332
Other limited partnership interests	14,186	14,764
Short-term investments, principally at estimated fair value	4,609	6,045
Other invested assets (includes $1,949 and $1,993, respectively, of leveraged and direct financing leases; $472 and $333, respectively, relating to variable interest entities)	19,706	18,202
Total investments	455,283	446,137
Cash and cash equivalents, principally at estimated fair value	21,765	20,639
Accrued investment income	3,722	3,589
Premiums, reinsurance and other receivables	31,443	28,971
Market risk benefits, at estimated fair value	310	286
Deferred policy acquisition costs and value of business acquired	20,401	20,151
Current income tax recoverable	304	190
Deferred income tax asset	2,469	2,612
Goodwill	9,155	9,236
Other assets	11,315	11,139
Separate account assets	148,809	144,634
Total assets	704,976	687,584
Liabilities
Future policy benefits	201,340	196,406
Policyholder account balances	224,609	219,269
Market risk benefits, at estimated fair value	3,117	3,179
Other policy-related balances	19,932	19,736
Policyholder dividends payable	381	386
Payables for collateral under securities loaned and other transactions	17,132	17,524
Short-term debt (includes $132 and $0, respectively, relating to variable interest entities)	404	119
Long-term debt	15,278	15,548
Collateral financing arrangement	529	637
Junior subordinated debt securities	3,163	3,161
Deferred income tax liability	956	927
Other liabilities (includes $25 and $0, respectively, relating to variable interest entities)	38,162	35,805
Separate account liabilities	148,809	144,634
Total liabilities	673,812	657,331
Contingencies, Commitments and Guarantees (Note 19)
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference	0	0
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,194,027,818 and 1,191,823,651 shares issued, respectively; 693,651,782 and 730,821,111 shares outstanding, respectively	12	12
Additional paid-in capital	33,766	33,690
Retained earnings	41,765	40,146
Treasury stock, at cost; 500,376,036 and 461,002,540 shares, respectively	(27,418)	(24,591)
Accumulated other comprehensive income (loss)	(17,240)	(19,242)
Total MetLife, Inc.’s stockholders’ equity	30,885	30,015
Noncontrolling interests	279	238
Total equity	31,164	30,253
Total liabilities and equity	$ 704,976	$ 687,584